Kruse Bo 4
4 · Y-mAbs Therapeutics, Inc. · Filed Jan 22, 2024
Insider Transaction Report
Form 4
Kruse Bo
DirectorEVP, CFO, Secy & Treas.
Transactions
- Award
Common Stock
2024-01-18+18,100→ 210,877 total - Award
Employee Stock Option (right to buy)
2024-01-18+108,900→ 108,900 totalExercise: $9.83Exp: 2034-01-18→ Common Stock (108,900 underlying)
Footnotes (3)
- [F1]Represents 18,100 restricted stock units ("RSUs") granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc. Each RSU represents a contingent right to receive one share of Common Stock on the vesting dates of the RSU. The RSUs vest by 1/3 on each of January 18, 2025, January 18, 2026 and January 18, 2027 subject to the continuing employment of the Reporting Person on each vesting date.
- [F2]Stock options granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
- [F3]The stock options shall vest and become exercisable as to 25% of the shares subject to the option on January 18, 2025, and thereafter vest and become exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.